Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × amrubicin × Clear all

Phase

Status

Completed 13 Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 509 Specimen Handling 403 Carboplatin 385 Magnetic Resonance Spectroscopy 371 Cisplatin 359 Cyclophosphamide 344 Radiotherapy 287 Gemcitabine 272 Bevacizumab 262 Paclitaxel 256 Biopsy 222 Drug Therapy 212 venetoclax 205 fludarabine 200 Capecitabine 199 Nivolumab 194 Oxaliplatin 193 Docetaxel 183 Injections 181 Fluorouracil 169 Dexamethasone 161 Radiosurgery 152 Rituximab 142 Pemetrexed 139 durvalumab 127 Standard of Care 127 atezolizumab 123 tislelizumab 120 toripalimab 115 Doxorubicin 115

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06203210 2026-03-02

IDeate-Lung02

Daiichi Sankyo

Phase 3 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡